Cautionary note about prostates
The story was crystal clear about the lack of benefit from the use of hormone therapy to treat older men with localized prostate cancer in terms of overall survival or risk of death from prostate cancer. The story was very complete and then included information about the subset of patients - those older men with localized prostate cancer with a more aggressive cell who comprised about 5% of the study population and appeared to derive some benefit in terms of reducing the number that died of prostate cancer but still without enhancement of overall survival.
Allergen Block: Invisible shield or invisible results?
There is no data showing the products works, and the reporter makes this clear.
Lacking data to report, the author clearly lays out the company's claims and then includes rebuttals from experienced allergists.
Debate surrounds new prostate cancer treatment
The story noted something that rarely gets mentioned: "a recent Agency for Healthcare Research and Quality study, which found that no prostate-cancer treatment was superior to the others. The report also noted the lack of good comparative studies."